Key Takeaways
- PDLLA is described as a biostimulator — it prompts the body, rather than filling space
- Particles are described as dissolving over months, with the collagen produced during that window remaining
- Structural changes reported in clinical sources are gradual — typically 3–6 months
- Juvelook pairs PDLLA with hyaluronic acid, adding a shorter-term hydration effect early on
The confusing part is that nothing is really being added to your face — at least, not in the way most people expect. People often arrive expecting the logic of a filler, where a substance goes in and occupies space. Juvelook is described differently, and once you see how it is characterised, the timeline stops feeling odd.
What is in the syringe
PDLLA stands for poly-D,L-lactic acid — a polymer of lactic acid, the same compound produced by muscles during hard exercise, assembled into long chains and formed into microparticles. In Juvelook, those particles are described by clinical sources as suspended in hyaluronic acid, which is discussed as serving two roles: making the material easier to place, and holding water in the skin while the slower process gets going.
The particles themselves are described as spherical and porous, with small openings across the surface that are said to increase the area available for cells to interact with.
Why nothing happens on day one
Collagen synthesis is not commonly described as fast. Visible structural change is generally discussed in clinical sources as appearing somewhere between three and six months after treatment — a function of the biology involved rather than a shortcoming in the product.
Protocols reported by clinical sources typically run two to three sessions spaced four to six weeks apart, with maintenance commonly discussed somewhere between 12 and 18 months.
There is a wrinkle here that can cause confusion. The hyaluronic-acid carrier is commonly described as producing a hydration effect quite quickly, so skin can look better within days. That is the HA doing what HA does; the PDLLA has barely started. People who judge the treatment at the two-week mark are often reacting to the wrong ingredient.
What the evidence covers
The broader PLLA category has reasonable published support. A systematic review in Aesthetic Plastic Surgery (2025), covering 14 studies at Level I evidence, reported PLLA results lasting up to 25 months, with improvements in skin elasticity, wrinkle appearance, and facial volume. Adverse events were mostly mild — chiefly pain and swelling at the injection site.
Regulatory status for the injectable form varies by country and changes over time; the current position where you live is worth checking directly.
Patience is part of the protocol
This is a treatment commonly described as rewarding a long view. If what you want is a change you can see next week, there are other things on the menu, and there is nothing wrong with wanting that instead. If the slower route appeals, some people find it useful to ask how many sessions the provider would suggest and what they would expect to be visible at each stage.
Sources ▶ 1) Antonini M. et al., Aesthetic Plastic Surgery (2025) — PLLA and CaHA Biostimulators Systematic Review; 2) Park et al., Skin Research and Technology (2026) — PDLLA vs PLLA split-face study; 3) ClinicalTrials.gov — NCT05913102.
